Literature DB >> 32483362

Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Kirsten L Bryant1, Clint A Stalnecker1, Daniel Zeitouni1, Jennifer E Klomp1, Sen Peng2, Andrey P Tikunov3, Venugopal Gunda4, Mariaelena Pierobon5, Andrew M Waters1, Samuel D George1, Garima Tomar1, Björn Papke1, G Aaron Hobbs1, Liang Yan6, Tikvah K Hayes7, J Nathaniel Diehl7, Gennifer D Goode4, Nina V Chaika4, Yingxue Wang8, Guo-Fang Zhang8, Agnieszka K Witkiewicz9, Erik S Knudsen10, Emanuel F Petricoin5, Pankaj K Singh4, Jeffrey M Macdonald3, Nhan L Tran11, Costas A Lyssiotis12, Haoqiang Ying6, Alec C Kimmelman13, Adrienne D Cox1,14,15, Channing J Der16,17,18.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32483362     DOI: 10.1038/s41591-020-0947-8

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  5 in total

1.  ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression.

Authors:  Kang Yang; Lan Luan; Xinyu Li; Xu Sun; Jian Yin
Journal:  J Neurooncol       Date:  2021-11-19       Impact factor: 4.130

Review 2.  KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer.

Authors:  Manxiong Dai; Shaofeng Chen; Xiong Teng; Kang Chen; Wei Cheng
Journal:  J Cancer       Date:  2022-08-31       Impact factor: 4.478

3.  Matairesinol Induces Mitochondrial Dysfunction and Exerts Synergistic Anticancer Effects with 5-Fluorouracil in Pancreatic Cancer Cells.

Authors:  Woonghee Lee; Gwonhwa Song; Hyocheol Bae
Journal:  Mar Drugs       Date:  2022-07-25       Impact factor: 6.085

4.  Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways.

Authors:  Zimin Chen; Jiahui Gao; Jun Sun; Zhouguang Wu; Bin Wang
Journal:  Med Sci Monit       Date:  2021-02-23

Review 5.  Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition.

Authors:  Xuan Wang; Yunhao Li; Jianqing Lu; Xiongwei Deng; Yan Wu
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.